Lenvima (lenvatinib)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   May 2016 WARNINGS AND PRECAUTIONS Hypertension In Study 2 in RCC, hypertension was reported in 42% of patients in the...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts